Molecular basis of 6-hydroxydopamine-induced caspase activations due to increases in oxidative stress in the mouse striatum

Neuroscience Letters

Volumn 410, Issue 2, 2006, Pages 85-89

  Tanaka, Ken ichi ^a   Ogawa, Norio ^b   Asanuma, Masato ^b  

^a SHUJITSU UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

6 Hydroxydopamine; Caspase; Glutathione; Mice; Oxidative stress; Parkinson's disease; Striatum

Indexed keywords

CASPASE; CASPASE 3; GLUTATHIONE; OXIDOPAMINE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC ACTIVITY; ENZYME ACTIVATION; LIPID PEROXIDATION; MALE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADRENERGIC AGENTS; ANALYSIS OF VARIANCE; ANIMALS; CASPASES; CORPUS STRIATUM; DOPAMINE; ENZYME ACTIVATION; MALE; MICE; MICE, INBRED ICR; OXIDATIVE STRESS; OXIDOPAMINE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS;

EID: 33750736984     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.08.021     Document Type: Article

References (31)

1. Alves Da Costa C., Paitel E., Vincent B., and Checler F. Alpha-synuclein lowers p53-dependent apoptotic response of neuronal cells. Abolishment by 6-hydroxydopamine and implication for Parkinson's disease. J. Biol. Chem. 277 (2002) 50980-50984
2. Asanuma M., Miyazaki I., and Ogawa N. Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's Disease. Neurotoxicity Res. 5 (2003) 165-176
3. Ben-Shachar D., Eshel G., Finberg J.P.M., and Youdim M.B.H. The iron chelator desferrioxamine (desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons. J. Neurochem. 56 (1991) 1441-1444
4. Berger K., Przedborski S., and Cadet J.L. Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats. Brain Res. Bull. 26 (1991) 301-307
5. Blum D., Torch S., Lambeng N., Nissou M., Benabid A.L., Sadoul R., and Verna J.M. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 65 (2001) 135-172
6. Bredesen D.E. Neural apoptosis. Ann. Neurol. 38 (1995) 839-851
7. Breese G.R., and Traylor T.D. Effects of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons. J. Pharma. Exp. Thera. 174 (1970) 413-420
8. Buege J.A., and Aust S.D. Microsomal lipid peroxidation. In: Fleisher S., and Packer L. (Eds). Methods in Enzymology vol. 52 (1978), Academic Press, New York 302-310
9. Cadet J.L., Last R., Kostic V., Przedborski S., and Jackson-Lewis V. Long-term behavioral and biochemical effects of intrastriatal injections of 6-hydroxydopamine. Brain Res. Bull. 26 (1991) 707-713
10. Chandra J., Samali A., and Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic. Biol. Med. 29 (2000) 323-333
11. Chase T.N. The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease. Drugs 55 (1998) 1-9
12. Cohen G. Monoamine oxidase, hydrogen peroxide, and Parkinson's disease. Adv. Neurol. 45 (1986) 119-125
13. Cooper A.J.L., and Kristal B.S. Multiple roles of glutathione in the central nervous system. Biol. Chem. 378 (1997) 793-802
14. Hall A. The role of glutathione in the regulation of apoptosis. Eur. J. Clin. Invest. 29 (1999) 238-245
15. Heikkila R.E., and Cohen G. 6-Hydroxydopamine: evidence for superoxide radical as an oxidative intermediate. Science 181 (1973) 456-457
16. Higashi Y., Asanuma M., Miyazaki I., Haque M.E., Fujita N., Tanaka K., and Ogawa N. The p53-activated gene, PAG608, requires a zinc finger domain for nuclear localization and oxidative stress-induced apoptosis. J. Biol. Chem. 277 (2002) 42224-42232
17. Iida M., Miyazaki I., Tanaka K., Kabuto H., Iwata-Ichikawa E., and Ogawa N. Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist. Brain Res. 838 (1999) 51-59
18. Jenner P., and Olanow C.W. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47 (1996) 161-170
19. Liu J., Wang X., Shigenaga M.K., Yeo H.C., Mori A., and Ames B.N. Immobilization stress causes oxidative damage to lipid, protein, and DNA in the brain of rats. FASEB J. 10 (1996) 1532-1538
20. Michel P.P., and Hefti F. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in cluture. J. Neurosci. Res. 26 (1990) 428-435
21. Ogawa N., Edamatsu R., Mizukawa K., Asanuma M., Kohno M., and Mori A. Degeneration of dopaminergic neurons and free radicals: possible participation of levodopa. Adv. Neurol. 60 (1993) 242-250
22. Peter M.E., and Krammer P.H. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr. Opin. Immunol. 10 (1998) 545-551
23. Saleh A., Srinivasula S.M., Acharya S., Fishel R., and Alnemri E.S. Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J. Biol. Chem. 274 (1999) 17941-17945
24. Takata M.K., Yamaguchi F., Nakanose K., Watanabe Y., Hatano N., Tsukamoto I., Nagata M., Izumori K., and Tokuda M. Neuroprotective effect of D-psicose on 6-hydroxydopamine- induced apoptosis in rat pheochromocytoma (PC12) cells. J. Biosci. Bioeng. 100 (2005) 511-516
25. Tanaka K., Asanuma M., and Ogawa N. Molecular basis of anti-apoptotic effect of immunophilin ligands on hydrogen peroxide-induced apoptosis in human glioma cells. Neurochem. Res. 29 (2004) 1529-1536
26. Tanaka K., and Ogawa N. Dopamine agonist cabergoline inhibits levodopa-induced caspase activation in 6-OHDA-lesioned mice. Neurosci. Res. 51 (2005) 9-13
27. Tiffani-Castiglioni E., Saneto R.P., Proctor P.H., and Perez-Polo J.R. Participation of active oxygen species in 6-hydroxydopamine toxicity to a human neuroblastoma cell line. Biochem. Pharmacol. 31 (1982) 181-188
28. Ungerstedt U. 6-Hydroxydopamine induced degeneration of central monoamine neurons. Eur. J. Pharma. 5 (1968) 107-110
29. Wang X.F., and Cynader M.S. Astrocytes provide cysteine to neurons by releasing glutathione. J. Neurochem. 74 (2000) 1434-1442
30. Yoshioka M., Tanaka K., Miyazaki I., Fujita N., Higashi Y., Asanuma M., and Ogawa N. The dopamine agonist cabergoline provides neuroprotection by activation of the glutathione system and scavenging free radicals. Neurosci. Res. 43 (2002) 259-267
31. Zou H., Li Y., Liu X., and Wang X. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274 (1999) 11549-11556